Clinical trials
Phase 2 Kidney Diseases trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2022 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AMAG Pharmaceuticals, Inc. | 1 |
| Alnylam Pharmaceuticals | 1 |
| Genzyme, a Sanofi Company | 1 |
| Novartis Pharmaceuticals | 1 |
| Novo Nordisk A/S | 1 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 |
| Queen Margaret University | 1 |
| River 3 Renal Corp. | 1 |
| Steno Diabetes Center Copenhagen | 1 |
| University of Edinburgh | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kidney Diseases | 12 |
| Autoimmune Diseases | 2 |
| Diabetic Nephropathies | 2 |
| Genetic Diseases, Inborn | 2 |
| Glomerulonephritis | 2 |
| Glomerulonephritis, IGA | 2 |
| Hyperoxaluria, Primary | 2 |
| Immune System Diseases | 2 |
| Nephritis | 2 |
| Nephritis, Hereditary | 2 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.